Prelude Therapeutics Participates in Chardan Healthcare Conference

• Prelude Therapeutics will participate in the Chardan Healthcare Conference in New York City on October 20, 2026.
• Chief Scientific Officer Peggy Scherle and Chief Financial Officer Bryant Lim will join a fireside chat at 2 p.m. ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prelude Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610161601PRIMZONEFULLFEED9847386) on October 16, 2026, and is solely responsible for the information contained therein.